News | January 26, 2024
Laurus Labs inks JV agreement with KRKA, Slovenia
The registered capital of the newly founded company is € 50 million
The registered capital of the newly founded company is € 50 million
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
An accomplished R&D leader and champion of the application of AI to drug discovery
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Subscribe To Our Newsletter & Stay Updated
